Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (806)	5/4/1998 5:21:00 PM
From: BD	Read Replies (1) \| Respond to of 887

Your post may have been premature. It looks like the Cancer cure rumors are hitting Depo. I really don't think without Phase I data you'll see euphoria sustained. Depo will be in the teens or back at 2-3 by September, upon NDA approval or disaproval. Long term this is a delvery system not soley Depocyst drug company and you will see other long term opportunities if DC isn't approved. ENMD has got a long way to go before it will impact anti-cancer drug market. I relly hope the angiostatin is the miracle cure we've all been waiting for and would gladly take a beating with Depo to see this hedious desiese erradicated. Thanks Brian